Sonova's Consumer Hearing Divestment Sharpens Strategic Focus
Sonova is a Swiss-based global leader in hearing care, focused on hearing aids and cochlear implants.
Sonova Holding AG SOON
Bulls Say, Bears Say
Bulls
Sonova holds the largest market share in hearing aids and has strong exposure to the high-margin premium independent audiologist channel, which is considered highly sticky.
Bears
While Sonova’s current leadership in AI is a competitive advantage, competitors could leapfrog with their own implementations, potentially eroding Sonova’s premium pricing.
News
Trading Information
- Previous Close Price
- CHF 274.20
- Day Range
- CHF 272.40–276.00
- 52-Week Range
- CHF 163.00–276.00
- Bid/Ask
- CHF 273.40 / CHF 273.80
- Shares Outstanding
- 59.40M
- Market Cap
- CHF 16.25B
- Volume/Avg
- 36,831 / 137,999
Key Statistics
- Price/Earnings (Normalized)
- 26.98
- Price/Sales
- 4.47
- Dividend Yield (Trailing)
- 1.71%
- Dividend Yield (Forward)
- 1.71%
- Dividend Payment Schedule
- Jun
- Total Yield
- 2.07%
Company Profile
Sonova is one of the world's largest manufacturers and distributors of hearing aids. The company is based in Switzerland and distributes its products in more than 100 countries through its internal sales team and independent retailers. It also sells cochlear implants and audio technologies.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 18,447
- Website
- https://www.sonova.com
Competitors
Valuation
|
Metric
|
SOON
|
DEMANT
|
|---|---|---|
Price/Earnings (Normalized) | 26.98 | 29.02 |
Price/Book Value | 6.15 | 6.66 |
Price/Sales | 4.47 | 3.04 |
Price/Cash Flow | 20.88 | 17.51 |
Price/Earnings
SOON
DEMANT
Financial Strength
|
Metric
|
SOON
|
DEMANT
|
|---|---|---|
Quick Ratio | 1.17 | 0.54 |
Current Ratio | 1.75 | 0.82 |
Interest Coverage | 23.14 | 6.70 |
Quick Ratio
SOON
DEMANT
Profitability
|
Metric
|
SOON
|
DEMANT
|
|---|---|---|
Return on Assets (Normalized) | 11.07% | 6.76% |
Return on Equity (Normalized) | 24.50% | 24.80% |
Return on Invested Capital (Normalized) | 16.97% | 9.75% |
Return on Assets
SOON
DEMANT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|NtQdB?p | LOCK|Rx^$ | $181B | |||
| Medtronic PLC
MDT
| LOCK|kl>Xf% | LOCK|r$D> | $122B | |||
| Stryker Corp
SYK
| LOCK|&&?M&W&H | LOCK|>t> | $112B | |||
| Boston Scientific Corp
BSX
| LOCK|d%@$ds | LOCK|T>N^% | $64B | |||
| Edwards Lifesciences Corp
EW
| LOCK|k%&yY#v! | LOCK|Gs>Sg | $51B | |||
| DexCom Inc
DXCM
| LOCK|wdm&zVQS | LOCK|S<$^ | $33B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|^!C>yG | LOCK|%<n | $32B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|!R | LOCK|Km% | $25B | |||
| Steris PLC
STE
| LOCK|S>QJ<$N | LOCK|@h<S | $22B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|q#lm>L<@ | LOCK|l&> | $18B |
United States